I.G. Investment Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-8,455
Closed -$950K 464
2016
Q3
$950K Buy
8,455
+1,491
+21% +$172K ﹤0.01% 664
2016
Q2
$863K Buy
+6,964
New +$841K ﹤0.01% 679
2015
Q1
Sell
-4,700
Closed -$566K 870
2014
Q4
$566K Hold
4,700
﹤0.01% 720
2014
Q3
$688K Sell
4,700
-22,236
-83% -$3.43M ﹤0.01% 654
2014
Q2
$4.5M Sell
26,936
-34,913
-56% -$6.21M 0.02% 360
2014
Q1
$12.3M Buy
61,849
+1,500
+2% +$283K 0.04% 201
2013
Q4
$11.5M Sell
60,349
-600
-1% -$112K 0.04% 216
2013
Q3
$10.3M Sell
60,949
-8,200
-12% -$1.27M 0.04% 220
2013
Q2
$10.5M Buy
+69,149
New +$9.8M 0.04% 217

Other funds holding CLB

I.G. Investment Management's CLB Position: Q4 2016 in Review

I.G. Investment Management sold out of Core Laboratories (CLB) in Q4 2016, closing a stake of 8,455 shares — an estimated $950K sold.

I.G. Investment Management first reported a position in CLB in Q2 2013 and held it in 9 quarters. The position peaked at $12.3M in Q1 2014. 372 funds tracked by Wall St. Rank hold CLB as of Q4 2016.

  • I.G. Investment Management reported no remaining Core Laboratories position as of Q4 2016 after selling out during the quarter.
  • I.G. Investment Management sold 8,455 Core Laboratories shares in Q4 2016, an estimated $950K.
  • I.G. Investment Management first reported a position in Core Laboratories in Q2 2013 and held it in 9 quarters.
  • I.G. Investment Management's Core Laboratories position peaked at $12.3M in Q1 2014.
  • 372 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2016.

Based on I.G. Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.